Unveiling Cellular Responses and Underlying Immune Effects Induced by Boron Neutron Capture Therapy.

Clicks: 20
ID: 281584
2025
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Boron Neutron Capture Therapy (BNCT) is an emerging modality for cancer treatment. Although its concept was proposed in the last century, progress has been relatively slow due to limitations in neutron source technology and boron compounds. In recent years, with the increased availability of neutron devices and improvements in boron compounds, the radiobiological effects of BNCT have been investigated more deeply, leading to a surge of research findings in the field. Therefore, a systematic review of the current status of BNCT is particularly warranted. In this review, we integrate the latest studies to provide a comprehensive and detailed description of the direct and indirect mechanisms by which BNCT induces cell killing, as well as the subsequent cellular responses. More importantly, we propose that BNCT exhibits a stronger immunological foundation and immunogenicity compared to traditional radiotherapy, indicating significant potential for its combined application with immunotherapy. These results offer a robust theoretical foundation for the future clinical use of BNCT and indicate that continued investigation of BNCT in conjunction with immunotherapy may pave the way for more advanced cancer treatment strategies.
Reference Key
mao2025unveiling Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Mao, Hongyuan; Li, Jinyue; Huang, Chenhan; Li, Zerun; Ma, Xinyue; Jiang, Dizhi; Zhang, Xinyu; Wang, Tianzi; Cheng, Bo; Wang, Ruiqing; Wang, Jianbo; Cheng, Yufeng
Journal international journal of radiation oncology, biology, physics
Year 2025
DOI
10.1016/j.ijrobp.2025.04.026
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.